INTRODUCTION: Direct and indirect effects of chronic disease on sexual health are frequent and complex, but guidelines for their optimal management are lacking. With improved surgical and medical treatment of the underlying disease, the numbers of men and women needing assessment and management of associated sexual dysfunction are increasing. AIM: To provide recommendations/guidelines for the clinical management of sexual dysfunction within the context of chronic illness. METHODS: An international consultation in collaboration with the major sexual medicine associations assembled 186 multidisciplinary experts from 33 countries into 25 committees. Nine experts from four countries compiled the recommendations of sexual dysfunction in chronic illness and cancer with four focusing on neurological, renal, and psychiatric disease and lower urinary tract symptoms (LUTS). Searches were conducted using Medline, Embase, Lilacs, and Pubmed databases. MAIN OUTCOME MEASURES: Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation, and debate. RESULTS: Some conclusions concerning prevalence and pathophysiology of sexual dysfunction in the context of neurological disorders, end-stage renal failure, LUTS, and psychiatric disease were made. Optimal assessment of the multiple factors affecting sexuality when one or both partners are chronically ill is outlined. Evidence-based recommendations for management are presented. Comorbid depression is frequent and independently determines prevalence of sexual dysfunction in many conditions. CONCLUSIONS: There is need for more research and scientific reporting on prevalence, pathophysiology, and optimal treatment of sexual dysfunction associated with chronic illness. Screening for and managing comorbid depression is strongly recommended.
INTRODUCTION: Direct and indirect effects of chronic disease on sexual health are frequent and complex, but guidelines for their optimal management are lacking. With improved surgical and medical treatment of the underlying disease, the numbers of men and women needing assessment and management of associated sexual dysfunction are increasing. AIM: To provide recommendations/guidelines for the clinical management of sexual dysfunction within the context of chronic illness. METHODS: An international consultation in collaboration with the major sexual medicine associations assembled 186 multidisciplinary experts from 33 countries into 25 committees. Nine experts from four countries compiled the recommendations of sexual dysfunction in chronic illness and cancer with four focusing on neurological, renal, and psychiatric disease and lower urinary tract symptoms (LUTS). Searches were conducted using Medline, Embase, Lilacs, and Pubmed databases. MAIN OUTCOME MEASURES: Expert opinion was based on grading of evidence-based medical literature, widespread internal committee discussion, public presentation, and debate. RESULTS: Some conclusions concerning prevalence and pathophysiology of sexual dysfunction in the context of neurological disorders, end-stage renal failure, LUTS, and psychiatric disease were made. Optimal assessment of the multiple factors affecting sexuality when one or both partners are chronically ill is outlined. Evidence-based recommendations for management are presented. Comorbid depression is frequent and independently determines prevalence of sexual dysfunction in many conditions. CONCLUSIONS: There is need for more research and scientific reporting on prevalence, pathophysiology, and optimal treatment of sexual dysfunction associated with chronic illness. Screening for and managing comorbid depression is strongly recommended.
Authors: Ryan W Frieben; Hao-Cheng Lin; Peter P Hinh; Francesco Berardinelli; Steven E Canfield; Run Wang Journal: Asian J Androl Date: 2010-05-17 Impact factor: 3.285
Authors: Iona K Machado; Paula M Luz; Jordan E Lake; Rodolfo Castro; Luciane Velasque; Jesse L Clark; Valdilea G Veloso; Beatriz Grinsztejn; Raquel B De Boni Journal: Int J STD AIDS Date: 2017-02-02 Impact factor: 1.359
Authors: Melissa A Farmer; Alison Leja; Emily Foxen-Craft; Lindsey Chan; Leigh C MacIntyre; Tina Niaki; Mengsha Chen; Josiane C S Mapplebeck; Vanessa Tabry; Lucas Topham; Melissa Sukosd; Yitzchak M Binik; James G Pfaus; Jeffrey S Mogil Journal: J Neurosci Date: 2014-04-23 Impact factor: 6.167